FDA Allows Marketing of First Rapid Ebola Test

14:27 EDT 10 Oct 2019 | Medscape

The FDA has allowed marketing of the first rapid diagnostic test (RDT) to identify Ebola virus antigens, or proteins, in certain body fluids from living and deceased individuals.
FDA Approvals

Original Article: FDA Allows Marketing of First Rapid Ebola Test


More From BioPortfolio on "FDA Allows Marketing of First Rapid Ebola Test"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...